Full peer-reviewed publications are pending
Patients with NASH-related cirrhosis are at high risk for dying from liver diseases. He continued: We wanted to assess whether glucagon-like peptide-1 (GLP-1) analogues will be able to reverse features of NASH-cirrhosis and also the validity and clinical utility of endpoints, whether histologic or noninvasive, in assessing improvements in cirrhosis due to NASH with semaglutide vs
Exactech Lawsuit In February 2022, Florida-based medical device company Exactech issued a recall on over 150,000 knee, ankle, and hip replacement devices
Pattern 2: Step down to a lower dose For some patients particularly those who reached goal at the maximum dose a lower maintenance dose preserves most of the appetite suppression while reducing cost, side effects, and the burden of long-term use at maximum dose
Zepbound (tirzepatide) presents another option, enhancing weight loss efficiency by targeting multiple hormones
NAD+ gives better results if you want to boost your brain function and long-term mental health